Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...
New SwiftArrayStudio analyzer and updated genotyping arrays deliver results in as little as 30 hours, enabling researchers to drive impactful, scalable genetic researchWALTHAM, Mass.--(BUSINESS WIRE)- ...
About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...
Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...
News-Medical.Net on MSN
Microarray platform could help predict immune‐mediated drug‐induced liver injury
Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in ...
This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...
Find out how asparagus and vanilla orchids demonstrate the importance of cell walls in plant survival and adaptability.
A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...
CINCINNATI—Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback